Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multilamellar liposome suspensions are used as biolubricants in synovial joints to reduce friction and wear on articular cartilage, particularly in conditions like osteoarthritis. They are composed of multiple concentric lipid bilayers, typically made from phospholipids such as DMPC and DPPC, and are designed to mimic or supplement natural joint lubricants.
Forms a lubricating layer on articular cartilage, reducing friction and wear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multilamellar Liposome Suspension (MLV Suspension).